Lihao Chu

First-line treatment disruption among post-menopausal women with HR+/HER2– metastatic breast cancer: a retrospective US claims study

Jipan Xie, N. Li, E. Du, 2017, Current medical research and opinion.

Real-world palbociclib dosing patterns and implications for drug costs in the treatment of HR+/HER2- metastatic breast cancer

Jipan Xie, E. Du, D. Tang, 2017, Expert opinion on pharmacotherapy.